Effect of Erythropoietin Therapy on the Lipid Profile in Patients with Chronic Kidney Disease – A Single Center Study
- *Corresponding Author:
- Ali J Hashim Al-Saedi
Faculty of Medicine-Al Kindy College of Medicine
University of Baghdad, Iraq
E-mail: [email protected]
Received Date: August 16, 2013; Accepted Date: September 17, 2013; Published Date: September 21, 2013
Citation: Al-Saedi AJH, Alwachi SN, Karim AHA(2013) Effect of Erythropoietin Therapy on the Lipid Profile in Patients with Chronic Kidney Disease – A Single Center Study. J Nephrol Ther 3:140. doi:10.4172/2161-0959.1000140
Copyright: © 2013 Al-Saedi AJH, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Dyslipidemia is common in chronic kidney disease patients and alterations in serum lipid profile vary widely depending on the level of kidney function. We studied two hundred Iraqi patients who were diagnosed as having chronic kidney disease from June 2011 to January 2013. They were given erythropoietin for seven months. One hundred sixty patients (80%) showed response to treatment with an improvement in lipid profile, while the other 40 patients (20%) showed no significant response to treatment. In conclusion, treatment with erythropoietin seems to positively influence the lipid profile in patients with chronic kidney disease.